Adjuvant radiotherapy in patients with high‐risk cutaneous Squamous Cell Carcinoma After surgery (SCC‐AFTER): patient and carer views regarding a proposed clinical trial.

Adjuvant radiotherapy in patients with high-risk cutaneous Squamous Cell Carcinoma After surgery (SCC-AFTER): patient and carer views regarding a proposed clinical trial It's certainly worth doing (Patient)</td></tr><tr><td>If you ... said it [radiotherapy] only benefits thirty percent of patients then there is a school of thought which would say, "Well a hundred percent of patients will want it", and hope that they are in the thirty percent. Dear Editor, Cutaneous squamous cell carcinoma (cSCC) represents the second most common cancer in the UK.1 High-risk cSCC represents a subgroup of this disease with higher risk of metastasis and death,2 and management remains unclear due to a shortage of randomized controlled trials (RCTs).3 We undertook Patient and Public Involvement (PPI) consultations with 13 patients and 3 carers with experience of cSCC, to explore their views about a trial that will investigate effectiveness of treating high-risk cSCC using surgical excision alone compared with surgery plus adjuvant radiotherapy. [Extracted from the article]